Tarsons Products (NSE:TARSONS) ROCE %: 5.22% (As of Mar. 2026)


NSE:TARSONS Tarsons Products Ltd NSE:TARSONS
82 GF Score
Price ₹266.60
GF Value ₹567.89
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Tarsons Products ROCE %?

Tarsons Products NSE:TARSONS +0.58% 82 ROCE % is 5.22% as of Mar. 2026. GuruFocus rates NSE:TARSONS with a GF Score™ of 82/100 and a GF Value™ of ₹567.89 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tarsons Products's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.22%.

Tarsons Products  (NSE:TARSONS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tarsons Products ROCE % Related Terms

Tarsons Products ROCE % Historical Data

* Premium members only.

The historical data trend for Tarsons Products's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tarsons Products ROCE % Chart

Tarsons Products Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 36.40 19.30 9.96 7.72 4.87

Tarsons Products Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.19 3.58 4.70 5.92 5.22
NSE:TARSONS
82GF Score
Tarsons Products Ltd NSE:TARSONS
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tarsons Products ROCE % Calculation

Tarsons Products's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=444.44/( ( (10800.4 - 1757.34) + (11858.2 - 2641.88) )/ 2 )
=444.44/( (9043.06+9216.32)/ 2 )
=444.44/9129.69
=4.87 %

Tarsons Products's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=480.84/( ( (0 - 0) + (11858.2 - 2641.88) )/ 1 )
=480.84/( ( 0 + 9216.32 )/ 1 )
=480.84/9216.32
=5.22 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.22% mean?
Tarsons Products (NSE:TARSONS) has a ROCE % of 5.22% as of Mar. 2026.
Is Tarsons Products' ROCE % too high?
Tarsons Products' current ROCE % is 5.22%. The Medical Devices & Instruments industry median ROCE % is 2.19. Tarsons Products' value of 5.22% is 138.4% above this industry median. Overall, Tarsons Products has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tarsons Products' ROCE % compare to ISRG and BDX?
Tarsons Products' ROCE % of 5.22% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.19. Tarsons Products' value of 5.22% is 138.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.19, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tarsons Products's current ROCE % of 5.22% is 138.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tarsons Products's current ROCE % is 5.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsons Products stock overvalued right now?
Based on GuruFocus' analysis, Tarsons Products (NSE:TARSONS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹567.89, compared to a current price of ₹266.60 — trading 53.1% below its estimated fair value. The current ROCE % is 5.22% and 138.4% above the Medical Devices & Instruments industry median of 2.19. Tarsons Products' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Tarsons Products (NSE:TARSONS), the current ROCE % is 5.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tarsons Products (NSE:TARSONS) Overvalued in 2026?

Based on GuruFocus' analysis, Tarsons Products stock appears to be undervalued. The current stock price of ₹266.60 is trading 53.1% below its estimated GF Value™ of ₹567.89. GuruFocus considers Tarsons Products to be Significantly Undervalued.

Key valuation signals for NSE:TARSONS:

  • ROCE %: 5.22%
  • GF Value™: ₹567.89 vs. price of ₹266.60 (53.1% below fair value)
  • GF Score™: 82/100 with 5 warning signs
  • Industry Position: 138.4% above the Medical Devices & Instruments median

No single metric tells the full story. See the NSE:TARSONS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tarsons Products Business Description

Other Exchanges 543399:India
Address Martin Burn Buisness Park, Room No. 902, BP- 3, Salt Lake, Sector-V, Kolkata, WB, IND, 700091
Tarsons Products Ltd is an Indian labware Company engaged in designing, developing, manufacturing, and marketing consumables, reusables, and other including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies, and hospitals. The Company is also engaged in the manufacturing of a wide range of quality labware products that help scientific discovery and improve healthcare. The company generates the majority of its revenue from the sale of manufactured plastic products. Geographically, the company generates the majority of its revenue from India.
82GF Score

Get the complete analysis for NSE:TARSONS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹266.60
Price
₹567.89
GF Value